Friday, March 27, 2026 For Patients CME Credits Newsletters
Subscribe

Diabetes & Endocrinology

3 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
CFT Improves Depression and Emotional Eating in Severe Obesity: RCT Results
In a single-centre RCT with 91 participants, group-based Compassion Focused Therapy (CFT) significantly improved self-compassion, mood, and emotional eating in individuals with severe obesity compared…
Researchers studied how a special group therapy called Compassion Focused Therapy helps people with severe obesity. They found that this therapy improved feelings of self-worth, reduced emotional eati…
Web Portal Use in Type 2 Diabetes: Uptake Driven by Intentions, Not Frequency
In a secondary analysis of an RCT, higher education, openness, and intentions regarding physical activity and nutrition significantly increased web portal uptake in patients with type 2 diabetes or co…
This study looked at what influences people with diabetes and heart disease to start and keep using an online health tool. It found that education, openness to new ideas, and intentions to be active o…
High Infection Rates in Type 2 Diabetes: Periodontitis Prevalence at 33.6%
This meta-analysis found severe periodontitis prevalence at 33.6% (95% CI: 23.7-44.2) and lower respiratory tract infection incidence at 1409.2 per 10,000 person-years (95% CI: 1048.1-1894.6) in type …
Researchers looked at infections in people with type 2 diabetes and found that gum disease and lung infections are common. This information can help improve care for diabetes patients.…
CT.gov · Phase 3 Trial Evaluates Safety and Immunogenicity of CHIKV VLP Vaccine in Childr… CT.gov · Phase 2 Study: L-SABR Plus Standard Therapy in Metastatic NSCLC Patients CT.gov · Ivonescimab Phase II Study Targets 55% DCR in Relapsed Pleural Mesothelioma CT.gov · Phase 2 Study Evaluates Frexalimab, Brivekimig, Rilzabrutinib in FSGS and MCD CT.gov · Phase 2 Study: ManNAc for FSGS Shows Promise in Reducing Proteinuria CT.gov · Phase 3 Trial: Anifrolumab Shows Promise in SLE with BICLA Response as Primary O…